Bicocca Open Archive

Logo unimib boa
CONTER, VALENTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.112
AS - Asia 2.223
EU - Europa 1.768
SA - Sud America 343
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 8.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.966
SG - Singapore 829
CN - Cina 447
IT - Italia 361
VN - Vietnam 327
RU - Federazione Russa 306
BR - Brasile 261
HK - Hong Kong 248
DE - Germania 241
SE - Svezia 222
IE - Irlanda 149
CA - Canada 111
GB - Regno Unito 92
IN - India 85
FR - Francia 81
AT - Austria 53
UA - Ucraina 50
BD - Bangladesh 47
TR - Turchia 47
FI - Finlandia 46
AR - Argentina 30
ID - Indonesia 30
ES - Italia 29
PL - Polonia 29
IQ - Iraq 25
NL - Olanda 25
SA - Arabia Saudita 24
ZA - Sudafrica 20
DK - Danimarca 19
KR - Corea 19
MX - Messico 19
PH - Filippine 15
CO - Colombia 14
JP - Giappone 14
PK - Pakistan 14
BE - Belgio 13
EC - Ecuador 11
GR - Grecia 10
PE - Perù 8
VE - Venezuela 7
CL - Cile 6
EU - Europa 6
GT - Guatemala 6
JO - Giordania 6
PT - Portogallo 6
RO - Romania 6
UZ - Uzbekistan 6
AU - Australia 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
IL - Israele 5
MA - Marocco 5
NP - Nepal 5
AL - Albania 4
NO - Norvegia 4
CR - Costa Rica 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PY - Paraguay 3
SN - Senegal 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
IR - Iran 2
LB - Libano 2
MY - Malesia 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 8.504
Salva come PNG Salva come JPEG
Città #
Ann Arbor 677
Singapore 495
Ashburn 428
Hong Kong 243
Fairfield 242
San Jose 233
Chandler 219
Wilmington 171
Woodbridge 171
Frankfurt am Main 152
Dublin 148
Houston 144
New York 112
Seattle 109
Cambridge 89
Ho Chi Minh City 89
Dearborn 86
Hanoi 85
Los Angeles 84
Milan 83
Santa Clara 76
Toronto 75
Beijing 70
Chicago 59
Princeton 53
Vienna 45
Jacksonville 44
The Dalles 37
Hefei 33
Nanjing 32
Dallas 29
São Paulo 29
Altamura 28
Lauterbourg 27
Shanghai 27
Lawrence 26
Jakarta 25
Orem 24
Rome 24
Warsaw 24
Helsinki 22
Denver 21
Moscow 21
Buffalo 20
Grafing 20
London 20
Council Bluffs 18
Guangzhou 17
Munich 17
Chennai 16
Dong Ket 15
Paris 15
San Diego 15
Boardman 14
Montreal 13
Da Nang 12
Poplar 12
Seoul 12
Tokyo 12
Johannesburg 11
Nanchang 11
Ankara 10
Atlanta 10
Brussels 10
Dhaka 10
Haiphong 10
Jeddah 10
Mumbai 10
Naples 10
New Delhi 10
Phoenix 10
Turin 10
Baghdad 9
Bologna 9
Brooklyn 9
Rio de Janeiro 9
Salt Lake City 9
Stockholm 9
Turku 9
Istanbul 8
Kunming 8
Lissone 8
Nuremberg 8
Sulmona 8
Amsterdam 7
Andover 7
Athens 7
Belo Horizonte 7
Changsha 7
Mountain View 7
Perugia 7
Shenyang 7
Brasília 6
Hải Dương 6
Lachine 6
Medellín 6
Mexico City 6
Monza 6
Ottawa 6
Tashkent 6
Totale 5.498
Salva come PNG Salva come JPEG
Nome #
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 440
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 359
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 350
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 331
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 310
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 308
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 307
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 303
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 302
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 300
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 298
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 292
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 283
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 278
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 267
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 266
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 261
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases 259
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 248
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 246
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia 238
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 230
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study 229
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study 220
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia 217
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the Methodology 212
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 206
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 205
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 198
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 191
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia 173
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 164
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 155
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE 41
Building a Pediatric Hematopoietic Stem Cell Transplantation Unit In Paraguay: Lessons Learned 8
Totale 8.695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 0 68 80
2021/2022484 51 55 66 44 23 52 15 23 35 20 42 58
2022/2023867 88 262 50 85 46 132 15 77 53 2 47 10
2023/2024516 26 16 24 60 64 129 107 26 13 6 5 40
2024/20251.410 56 158 98 80 127 46 63 29 170 206 127 250
2025/20263.125 429 129 215 436 449 167 460 142 201 345 152 0
Totale 8.695